PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Total Non-Current Liabilities data on file, last reported at $139.3 million in Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 7.22% year-over-year to $139.3 million in Q1 2026; TTM through Mar 2026 was $139.3 million, a 7.22% increase from a year earlier, with the FY2025 full-year figure at $142.1 million, up 8.06% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $139.3 million, down from $142.1 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for PRCT reached as high as $142.1 million in Q4 2025 and fell as low as $66.6 million in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $117.3 million across 5 years, with a median of $122.1 million in 2024.
• Across the five-year window, Total Non-Current Liabilities surged 64.38% in 2023 and retreated 1.33% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $112.3 million in 2022, then increased by 9.97% to $123.4 million in 2023, then grew by 6.5% to $131.5 million in 2024, then grew by 8.06% to $142.1 million in 2025, then slipped by 1.96% to $139.3 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $139.3 million in Q1 2026, $142.1 million in Q4 2025, and $130.7 million in Q3 2025.